• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾素-血管紧张素系统各组分对血管紧张素原生成的反馈调节。

The feedback regulation of angiotensinogen production by components of the renin-angiotensin system.

作者信息

Herrmann H C, Dzau V J

出版信息

Circ Res. 1983 Mar;52(3):328-34. doi: 10.1161/01.res.52.3.328.

DOI:10.1161/01.res.52.3.328
PMID:6337739
Abstract

The in vivo generation of angiotensin appears to be dependent on both plasma renin and angiotensinogen concentrations. Much less is known about the control of hepatic angiotensinogen synthesis and release, as compared to that of renin. In this study, we examined the feedback regulation of angiotensinogen synthesis and release by various components of the renin-angiotensin system, using an in vitro rat liver slice system. Livers were removed for study from rats which were subjected to various systemic infusions or physiological perturbations. Infusion of angiotensin II has been reported to increase angiotensinogen release rate. However, infusion of angiotensin I (with simultaneous suppression of plasma renin by antirenin antibody infusion and angiotensin II production by captopril administration) had no effect on the angiotensinogen release rate. Direct infusion of renin in rats treated with captopril resulted in further suppression of the angiotensinogen release rate, compared with those given captopril alone. We postulate that renin (or des-angiotensin I-angiotensinogen) inhibits the angiotensinogen release rate, whereas angiotensin II stimulates it. Angiotensin I has no effect on angiotensinogen release rate. This hypothesis was evaluated further in rats with various physiological states. Indeed, when conditions were such that the renin-angiotensin system was completely suppressed, such as binephrectomy and antirenin antibody infusion, angiotensinogen release rate was markedly stimulated. When angiotensin II production was prevented by captopril treatment, angiotensinogen release rate declined. This appeared to be the case for all states of sodium balance. Thus, angiotensinogen release rate is subject to a complex feedback control by other components of the renin-angiotensin system.

摘要

血管紧张素在体内的生成似乎取决于血浆肾素和血管紧张素原的浓度。与肾素相比,人们对肝脏血管紧张素原合成和释放的调控了解较少。在本研究中,我们使用体外大鼠肝切片系统,研究了肾素-血管紧张素系统各组分对血管紧张素原合成和释放的反馈调节。从接受各种全身输注或生理扰动的大鼠身上取出肝脏进行研究。据报道,输注血管紧张素II可增加血管紧张素原释放速率。然而,输注血管紧张素I(同时通过输注抗肾素抗体抑制血浆肾素,并通过给予卡托普利抑制血管紧张素II生成)对血管紧张素原释放速率没有影响。与单独给予卡托普利的大鼠相比,在给予卡托普利的大鼠中直接输注肾素导致血管紧张素原释放速率进一步受到抑制。我们推测肾素(或脱血管紧张素I-血管紧张素原)抑制血管紧张素原释放速率,而血管紧张素II则刺激其释放。血管紧张素I对血管紧张素原释放速率没有影响。在处于各种生理状态的大鼠中进一步评估了这一假设。事实上,当肾素-血管紧张素系统被完全抑制时,如双侧肾切除和输注抗肾素抗体,血管紧张素原释放速率会受到明显刺激。当通过卡托普利治疗阻止血管紧张素II生成时,血管紧张素原释放速率下降。在所有钠平衡状态下似乎都是如此。因此,血管紧张素原释放速率受到肾素-血管紧张素系统其他组分的复杂反馈控制。

相似文献

1
The feedback regulation of angiotensinogen production by components of the renin-angiotensin system.肾素-血管紧张素系统各组分对血管紧张素原生成的反馈调节。
Circ Res. 1983 Mar;52(3):328-34. doi: 10.1161/01.res.52.3.328.
2
Liver angiotensinogen synthesis and release during captopril treatment in sodium-depleted rats.钠缺乏大鼠在卡托普利治疗期间肝脏血管紧张素原的合成与释放
Endocrinology. 1987 Apr;120(4):1384-90. doi: 10.1210/endo-120-4-1384.
3
Influence of converting-enzyme inhibition on rat des-angiotensin I-angiotensinogen.转换酶抑制对大鼠脱-血管紧张素I-血管紧张素原的影响。
Am J Physiol. 1984 Feb;246(2 Pt 1):E129-33. doi: 10.1152/ajpendo.1984.246.2.E129.
4
Cardiac angiotensinogen and its local activation in the isolated perfused beating heart.心脏血管紧张素原及其在离体灌注搏动心脏中的局部激活。
Circ Res. 1990 Sep;67(3):564-73. doi: 10.1161/01.res.67.3.564.
5
Influence of captopril treatment on angiotensin II receptors and angiotensinogen in the brain of spontaneously hypertensive rats.卡托普利治疗对自发性高血压大鼠脑内血管紧张素II受体及血管紧张素原的影响。
Hypertension. 1983 Nov-Dec;5(6):935-42. doi: 10.1161/01.hyp.5.6.935.
6
Angiotensin stimulates beta-endorphin release from anterior pituitary gland cell cultures of rats.血管紧张素刺激大鼠垂体前叶细胞培养物中β-内啡肽的释放。
Neurosci Lett. 1984 Apr 20;46(1):25-9. doi: 10.1016/0304-3940(84)90193-9.
7
The effects of converting enzyme inhibitors on plasma angiotensinogen and plasma aldosterone in sodium-depleted rats.
J Hypertens Suppl. 1983 Oct;1(1):37-40.
8
Angiotensin-converting enzyme blockade by Captopril changes angiotensin II receptors and angiotensinogen concentrations in the brain of SHR-sp and WKY rats.
Neurosci Lett. 1982 Dec 23;34(1):45-50. doi: 10.1016/0304-3940(82)90090-8.
9
Angiotensinogen is cleaved to angiotensin in isolated rat blood vessels.
Hypertension. 1993 Jun;21(6 Pt 2):1030-4. doi: 10.1161/01.hyp.21.6.1030.
10
Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.大鼠血浆和肾脏中血管紧张素肽水平的差异调节。
Hypertension. 1991 Dec;18(6):763-73. doi: 10.1161/01.hyp.18.6.763.

引用本文的文献

1
Urinary Angiotensinogen in Patients With Type 1 Diabetes With Microalbuminuria: Gender Differences and Effect of Intensive Insulin Therapy.1型糖尿病合并微量白蛋白尿患者的尿血管紧张素原:性别差异及强化胰岛素治疗的影响
Kidney Int Rep. 2022 Sep 20;7(12):2657-2667. doi: 10.1016/j.ekir.2022.09.010. eCollection 2022 Dec.
2
Renin-Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins.肝脏代谢中的肾素-血管紧张素系统:性别差异与肠促胰岛素的作用。
Metabolites. 2022 May 3;12(5):411. doi: 10.3390/metabo12050411.
3
Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus.
在1型糖尿病患者中,尿血管紧张素原先于3期慢性肾脏病的发生。
Physiol Rep. 2019 Oct;7(19):e14242. doi: 10.14814/phy2.14242.
4
Angiotensinogen as a biomarker of acute kidney injury.血管紧张素原作为急性肾损伤的生物标志物。
Clin Kidney J. 2017 Dec;10(6):759-768. doi: 10.1093/ckj/sfx087. Epub 2017 Jul 28.
5
Cys18-Cys137 disulfide bond in mouse angiotensinogen does not affect AngII-dependent functions in vivo.小鼠血管紧张素原中的Cys18-Cys137二硫键不影响体内血管紧张素II依赖性功能。
Hypertension. 2015 Apr;65(4):800-5. doi: 10.1161/HYPERTENSIONAHA.115.05166. Epub 2015 Feb 17.
6
Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension.血管紧张素II 1型受体相关蛋白的缺失增强肾钠重吸收并加剧血管紧张素II介导的高血压。
Kidney Int. 2014 Sep;86(3):570-81. doi: 10.1038/ki.2014.95. Epub 2014 Apr 2.
7
Urinary markers of intrarenal renin-angiotensin system activity in vivo.体内肾素-血管紧张素系统活性的尿标志物。
Curr Hypertens Rep. 2013 Apr;15(2):81-8. doi: 10.1007/s11906-012-0326-z.
8
Angiotensin II blockade and renal protection.血管紧张素 II 阻断与肾脏保护。
Curr Pharm Des. 2013;19(17):3033-42. doi: 10.2174/1381612811319170009.
9
Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.高血压和慢性肾脏病患者肾内和尿中的血管紧张素原增加。
Pflugers Arch. 2013 Jan;465(1):3-12. doi: 10.1007/s00424-012-1143-6. Epub 2012 Aug 24.
10
Central angiotensin II has catabolic action at white and brown adipose tissue.中枢血管紧张素 II 在白色和棕色脂肪组织中有分解代谢作用。
Am J Physiol Endocrinol Metab. 2011 Dec;301(6):E1081-91. doi: 10.1152/ajpendo.00307.2011. Epub 2011 Aug 23.